Omeros report successful OMS721 treatment of patient with HCT-TMA and GvHD
Omeros announced a case report of a patient having co-existing hematopoietic stem cell transplant-associated thrombotic microangiopathy and graft-versus-host disease, which both resolved following OMS721 treatment. The patient was a participant in an ongoing Phase 2 uncontrolled clinical trial. October 20, 2017